Alerts will be sent to your verified email
Verify EmailORTINGLOBE
|
Ortin Global
|
Shamrock Indl. Co
|
Parmax Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.67 % | 0.0 | 24.13 % |
|
5yr average Equity Multiplier
|
2.06 | 1.02 | 29.23 |
|
5yr Average Asset Turnover Ratio
|
0.28 | 0.0 | 1.05 |
|
5yr Avg Net Profit Margin
|
-124.59 % | 0.0 | -11.29 % |
|
Price to Book
|
9.24 | 10.25 | 0.0 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
1016.26 Days | 0.0 | -92.25 Days |
|
Inventory Days
|
326.59 Days | 0.0 | 69.37 Days |
|
Days Receivable
|
1081.4 Days | 0.0 | 20.01 Days |
|
Days Payable
|
645.07 Days | 0.0 | 296.94 Days |
|
5yr Average Interest Coverage Ratio
|
-64.13 | 0.0 | -0.77 |
|
5yr Avg ROCE
|
-34.49 % | -8.65 % | -14.3 % |
|
5yr Avg Operating Profit Margin
|
-107.87 % | 0.0 | 2.43 % |
|
5 yr average Debt to Equity
|
0.51 | 0.0 | 10.96 |
|
5yr CAGR Net Profit
|
n/a | -15.95 % | n/a |
|
5yr Average Return on Assets
|
-25.0 % | -8.47 % | -9.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
1.23 % | 43.36 % | 30.8 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-20.28 % | 0.38 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ortin Global
|
Shamrock Indl. Co
|
Parmax Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|